Evaluation and Management of White Vaginal Discharge
Immediate Diagnostic Workup
Perform point-of-care testing with vaginal pH measurement, saline wet mount microscopy, and 10% KOH preparation to differentiate between the three most common causes: bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis. 1
Step 1: Measure Vaginal pH
- Use narrow-range pH paper as the critical first step 1
- pH ≤4.5 indicates vulvovaginal candidiasis 1, 2
- pH >4.5 suggests bacterial vaginosis or trichomoniasis 3, 1
Step 2: Prepare Microscopy Slides
- Dilute vaginal discharge sample in 1-2 drops of 0.9% normal saline on one slide 3
- Place 1-2 drops of discharge in 10% KOH solution on a second slide 3
- Perform the "whiff test" immediately when applying KOH—a fishy odor indicates bacterial vaginosis or trichomoniasis 3
Step 3: Microscopic Examination
- Saline wet mount identifies motile trichomonads (trichomoniasis) or clue cells (bacterial vaginosis) 3, 1
- KOH preparation visualizes yeast or pseudohyphae confirming candidiasis 3, 1, 2
Diagnosis and Treatment by Specific Condition
Bacterial Vaginosis (Most Common Cause)
Bacterial vaginosis is the most prevalent cause of vaginal discharge, characterized by replacement of normal H2O2-producing Lactobacillus with high concentrations of anaerobic bacteria. 3
Diagnostic Criteria (Amsel Criteria - Need 3 of 4):
- Homogeneous, white, noninflammatory discharge that smoothly coats vaginal walls 3
- Clue cells on microscopic examination 3
- Vaginal pH >4.5 3
- Positive whiff test (fishy odor with KOH) 3
Treatment:
- First-line: Metronidazole 500 mg orally twice daily for 7 days 3, 4, 5
- Alternative: Metronidazole 2 g orally single dose 3
- Alternative: Intravaginal metronidazole gel or clindamycin cream 3, 1
- Advise patients to avoid alcohol during treatment and for 24 hours after 3
- Do not treat male partners—this does not prevent recurrence 3, 4
Vulvovaginal Candidiasis
Candidiasis presents with white, thick "cottage cheese" discharge, normal pH (≤4.5), and intense vulvar itching and burning. 2
Diagnostic Confirmation:
- Yeast or pseudohyphae visible on KOH preparation 1, 2
- Normal vaginal pH (≤4.5) 1, 2
- Erythema and swelling of vulvovaginal tissues 2
Treatment for Uncomplicated Cases:
- Oral fluconazole 150 mg single dose 1, 6
- Alternative: Topical azoles (clotrimazole, miconazole, terconazole) for 1-7 days 1, 2
Treatment for Complicated/Recurrent Cases (≥4 episodes/year):
- Initial: Topical azole therapy for 7-14 days OR fluconazole 150 mg every 72 hours for 3 doses 2, 4
- Maintenance: Fluconazole 150 mg weekly for 6 months 2, 4
Trichomoniasis
Trichomoniasis causes yellow-green, frothy, malodorous discharge with vulvar irritation. 1, 2
Diagnostic Confirmation:
- Motile trichomonads on saline wet mount 3, 1
- Vaginal pH >4.5 1
- Culture or NAAT for confirmation if wet mount negative 1
Treatment:
- Metronidazole 2 g orally single dose 1, 4
- Alternative: Metronidazole 500 mg twice daily for 7 days 1
- Treat sexual partners simultaneously to prevent reinfection 1, 2
Special Population Considerations
Pregnant Women:
- Treat all symptomatic pregnant women with bacterial vaginosis or trichomoniasis to reduce risk of preterm labor and premature rupture of membranes 1
- For candidiasis in pregnancy: Use ONLY 7-day topical azole therapy—oral fluconazole is contraindicated 1, 2, 4
- For bacterial vaginosis: Oral metronidazole 500 mg twice daily for 7 days is safe 4
HIV-Infected/Immunocompromised Women:
High-Risk Pregnant Women (Prior Preterm Delivery):
- Consider treating asymptomatic bacterial vaginosis to reduce prematurity risk 3
Critical Pitfalls to Avoid
- Never treat based solely on microscopic findings without symptoms—10-20% of women normally harbor Candida without infection 2
- Do not culture Gardnerella vaginalis for diagnosis—it lacks specificity and is present in 50% of normal women 3
- Avoid self-medication recommendations except for women previously diagnosed with candidiasis experiencing identical recurrent symptoms 2, 4
- Do not use vaginal douching—it disrupts normal flora and increases infection risk 4
- Metronidazole treatment can precipitate vulvovaginal candidiasis in 12.5-30% of patients—consider concurrent antifungal therapy when treating bacterial vaginosis in symptomatic women 2
When Laboratory Testing Fails
Laboratory testing fails to identify the cause among a substantial minority of women. 3 In these cases:
- Consider non-infectious causes: mechanical irritation, chemical irritation, allergic reaction, or atrophic vaginitis 3
- Look for objective signs of vulvar inflammation with minimal discharge 3
- Consider culture for Trichomonas (more sensitive than microscopy) 3